Rare Diseases Ireland
Lobbying activity
The following activities occurred for this specific Subject Matter Area.
Meeting (1)
Attended meeting as support for constituent with lived experience of a rare disease, multiple leukocyte dystrophy (MLD), who has first had experience of need for early diagnosis through NBS program and benefits of new drug (Libmeldy) currently being assessed for reimbursement.
Also highlighted the need to begin revision of national rare disease plan as promised in prog for government.
Designated public officials lobbied
The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.